Showing posts with label g fails to meet primary endpoint in clinical trial. Show all posts
Showing posts with label g fails to meet primary endpoint in clinical trial. Show all posts
Wednesday, June 22, 2016

Losmapimod drug fails to meet primary endpoint in clinical trial

›
Patients taking losmapimod, an anti-inflammatory drug currently being developed, for 12 weeks following a heart attack did not sho...